中国癌症杂志 ›› 2016, Vol. 26 ›› Issue (5): 399-403.doi: 10.3969/j.issn.1007-3969.2016.05.008

• 论著 • 上一篇    下一篇

恶性黑素瘤患者KIT基因突变分析

吕矫洁,孔蕴毅,蔡 旭,周晓燕   

  1. 复旦大学附属肿瘤医院病理科,复旦大学上海医学院肿瘤学系,上海200032
  • 出版日期:2016-05-30 发布日期:2016-06-23
  • 通信作者: 孔蕴毅 E-mail:kyunyidb@126.com
  • 基金资助:
    上海市自然科学基金(12ZR1406600);国家临床重点专科建设项目。

Analysis of KIT gene mutation in melanoma patients

LÜ Jiaojie, KONG Yunyi, CAI Xu, ZHOU Xiaoyan   

  1. Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Published:2016-05-30 Online:2016-06-23
  • Contact: KONG Yunyi E-mail: kyunyidb@126.com

摘要: 背景与目的:KIT基因突变在恶性黑素瘤的发生、发展中发挥了重要作用。该研究旨在探讨KIT基因在各种组织学类型恶性黑素瘤患者中的突变率和类型。方法:用聚合酶链反应(polymerase chain reaction,PCR)扩增和直接测序方法检测144例恶性黑素瘤患者肿瘤组织中KIT外显子9、11、13和17的突变情况。结果:KIT基因在恶性黑素瘤患者中的总体突变率为9.0%(13/144)。在肢端型、黏膜型、慢性日光损伤型(chronic sun-induced damage,CSD)和非慢性日光损伤型(non-chronic sun-induced damage,non-CSD)恶性黑素瘤组织中,KIT基因的突变率分别为7.7%(4/52)、20.0%(7/35)、14.3%(1/7)和2.8%(1/36);13例KIT基因突变中,有1例位于第9外显子,9例位于第11外显子,3例位于第13外显子。第11外显子L576P为最常见的突变类型。结论:KIT基因突变在恶性黑素瘤患者中最常见于第11外显子,它可能是恶性黑素瘤治疗药物作用的潜在靶点。

关键词: KIT, 基因突变, 恶性黑素瘤

Abstract: Background and purpose: KIT mutation plays an important role during the pathogenesis of melanoma. This study was designed to investigate the mutation status of KIT in different subtypes of melanoma. Methods: A total number of 144 cases of melanoma were analyzed for KIT mutation (exon 9, 11, 13 and 17) by DNA sequencing using paraffin-embedded tissues. Results: The total incidence of KIT mutation in melanoma was 9.0% (13/144). KIT mutations in acral melanoma, mucosal melanoma, melanoma on skin with chronic sun-induced damage (CSD) and melanoma on skin without chronic sun-induced damage (non-CSD) was 7.7% (4/52), 20% (7/35), 14.3% (1/7) and 2.8% (1/36), respectively. Among 13 cases with KIT mutation, 1 mutation lay in exon 9, 9 lay in exon 11 and 3 in exon 13. L576P in exon 11 was the most common type of mutation. Conclusion: The most prevalent type of KIT mutation in patients lies in exon 11. KIT mutation could be the potential drug target in melanoma therapy.

Key words: KIT, Gene mutation, Melanoma